Dissolution of multicomponent microbubbles in the bloodstream: 2. Experiment.

The effect of the nature of the filling gas on the persistence of microbubbles in the bloodstream was studied. All the microbubbles were covered with the same shells. Various perfluorocarbons and perfluoropolyethers alone and as mixtures with nitrogen were used as the filling gases. The persistence time of microbubbles in the bloodstream tau increased with the molecular weight of the filling gas, from approximately 2 min for perfluorethane, to > 40 min for perfluorodiglyme, C6F14O3, and then decreased again to 8 min for C6F14O5. An acceptable ultrasound scattering efficacy was exhibited by the filling gases with intermediate molecular weights that possessed both a high saturated vapor pressure and a comparatively low water solubility (Ostwald coefficient). On the basis of the experimental data, it is concluded that the microbubble persistence tau is controlled primarily by the dissolution of microbubbles and not by the removal of the microbubbles by the reticular endothelial system. Although the qualitative experimental trends are in good agreement with the theoretical model developed previously, there are some quantitative differences. Possible reasons for these differences are discussed.

[1]  A. Kabalnov,et al.  Solubility of fluorocarbons in water as a key parameter determining fluorocarbon emulsion stability , 1990 .

[2]  Loyd D. Hampton,et al.  Acoustics of gas‐bearing sediments I. Background , 1980 .

[3]  R Gramiak,et al.  Echocardiography of the aortic root. , 1968, Investigative radiology.

[4]  R. Schlief Developments in echo-enhancing agents. , 1996, Clinical Radiology.

[5]  B B Goldberg,et al.  Ultrasound contrast agents. , 1993, Clinics in diagnostic ultrasound.

[6]  M. Minnaert XVI.On musical air-bubbles and the sounds of running water , 1933 .

[7]  Nico de Jong,et al.  Acoustic properties of ultrasound contrast agents , 1993 .

[8]  J. Ingham,et al.  Methods for the estimation of vapor pressures and oxygen solubilities of fluorochemicals for possible application in artificial blood formulations. , 1978 .

[9]  F Forsberg,et al.  Ultrasound contrast agents: a review. , 1994, Ultrasound in medicine & biology.

[10]  G. Steinbach,et al.  Gas emulsions as ultrasound contrast agents. Preliminary results in rabbits and dogs. , 1994, Investigative radiology.

[11]  W. Lees,et al.  Ultrasound contrast agents. , 1994, Clinical radiology.

[12]  S. Renowden,et al.  Pictorial review: MR imaging of neuronal migration anomalies. , 1996, Clinical Radiology.

[13]  E. G. Tickner,et al.  Why do the lungs clear ultrasonic contrast? , 1980, Ultrasound in medicine & biology.

[14]  A. Anderson,et al.  Acoustics of Gas-Bearing Sediments. , 1974 .

[15]  A. Kabalnov,et al.  Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory. , 1998, Ultrasound in medicine & biology.

[16]  E. Unger,et al.  Gas-filled lipid bilayers as ultrasound contrast agents. , 1994, Investigative Radiology.

[17]  T. Porter,et al.  Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. , 1996, Journal of the American College of Cardiology.

[18]  T. Reed CHAPTER 2 – Physical Chemistry of Fluorocarbons , 1964 .

[19]  W R Lees,et al.  Technical report: spiral CT pneumocolon for suspected colonic neoplasms. , 1996, Clinical radiology.